Digg It - Business

RFID, Radio Frequency Identification of products and the Internet makes it possible to insure tha

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

t any single product can only be sold once. Cryptography is not necessary to insure that a once

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

only sold item is not a counterfeit.

If a product can be tracked from the producer to the end us

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

er with a unique identification, and a data base maintained when that product is sold, then it is

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

a simple matter to prevent counterfeiting. The pharmaceutical companies and their customers woul

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

d benefit greatly by solving the counterfeit problem.

When a product is scanned at the sales cou

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

nter, that information would be sent to the company data base and recorded as sold. If that iden

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

tification were ever reported as sold again, it would then be flagged as counterfeit. If an iden

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

ification were reported as sold that was not produced by that company, it would be flagged as cou

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

nterfeit. This process could be used through the entire distribution chain to insure that counte

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

rfeit product are not introduced at the distribution level. When the same identification shows u

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

p in two different locations then it would signal that one of them was counterfeit.

If the retai

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

er scans the product and reports the transaction to the company that produced the product, the bu

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

yer could be assured that the product is genuine.

Cryptography is useless because anyone with th

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

e right equipment can copy or produce the Data Security Tag. So just being able to read the tag

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

does not insure that it is not a counterfeit. You would have to know if that was in fact produce

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

by whom you think produced it and know that there is not another one out there waiting to be sol

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

d or already sold.

This solution is only valid for products that should be sold to the end user

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

once, such as pharmaceuticals. I would hope that if pharmaceutical companies are not already stu

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

dying this approach, they would do so now so that I can be assured that I will get what I pay for

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.diggit.org.ua/article/20169/diggit-RFID-Solution-to-Counterfeit-Products.html">RFID Solution to Counterfeit Products</a>

BB link (for phorums):
[url=http://www.diggit.org.ua/article/20169/diggit-RFID-Solution-to-Counterfeit-Products.html]RFID Solution to Counterfeit Products[/url]

Once you obtain business, do you give much thought to protecting yourself (and your income)? Often, we're so exhausted by our business-building efforts, and so exhilarated when we get it, that we simply shift to concentrating on closing the deal - and ignore potential adverse situations.

Do paid surveys really work? Can you earn a great income from your own home? Are they just a gigantic scam? The answer is yes and no to all three questions.

Tags

Links

Digg It - RFID Solution to Counterfeit Products

Related Articles: